Behling et al., 1977 - Google Patents
Immune adjuvancy of lipopolysaccharide and a nontoxic hydrolytic product demonstrating oscillating effects with timeBehling et al., 1977
View PDF- Document ID
- 11236175740685538429
- Author
- Behling U
- Nowotny A
- Publication year
- Publication venue
- The Journal of Immunology
External Links
Snippet
Since the first reports of immune adjuvancy of endotoxic lipopolysaccharides (LPS)(1, 2), large numbers of such preparations have proven to be effective adjuvants for both soluble and cellular immunogens in a host of laboratory animals (for review, see Neter (3)). Kind and …
- 239000002158 endotoxin 0 title abstract description 37
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K8/00—Cosmetic or similar toilet preparations
- A61K8/18—Cosmetic or similar toilet preparations characterised by the composition
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Dutton | Inhibitory and stimulatory effects of concanavalin A on the response of mouse spleen cell suspensions to antigen: I. Characterization of the inhibitory cell activity | |
Behling et al. | Immune adjuvancy of lipopolysaccharide and a nontoxic hydrolytic product demonstrating oscillating effects with time | |
Baldwin et al. | Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes | |
Gidlund et al. | Enhanced NK cell activity in mice injected with interferon and interferon inducers | |
Darcy et al. | Induction of a protective antibody‐dependent response against toxoplasmosis by in vitro excreted/secreted antigens from tachyzoites of Toxoplasma gondii | |
Notkins et al. | Elevated γ-globulin and increased antibody production in mice infected with lactic dehydrogenase virus | |
Wakabayashi et al. | The immunospecificity of nonhistone protein complexes with DNA | |
Cole et al. | Interactions of mycoplasmas and their products with lymphoid cells in vitro | |
Unanue | Thymus dependency of the immune response to hemocyanin: an evaluation of the role of macrophages in thymectomized mice | |
Boraschi et al. | Interferon‐induced enhancement of macrophage‐mediated tumor cytolysis and its difference from activation by lymphokines | |
US4323561A (en) | Process of enhancing immmunogenic response in mammals by the administration of synthetic glycolipid adjuvants | |
Fuson et al. | IgM-induced cell-mediated cytotoxicity with antibody and effector cells of human origin | |
CA2125181A1 (en) | Trophoblast interferons and their use | |
Schultze et al. | Demonstration of specifically sensitized lymphocytes in patients treated with an aqueous mistletoe extract (Viscum album L.) | |
Lonai et al. | Studies on the effect of a thymic humoral factor on differentiation of thymus‐derived lymphocytes | |
Behling | The radioprotective effect of bacterial endotoxin | |
Nishioka et al. | Tuftsin: an immunomodulating peptide hormone and its clinical potential as a natural biological response modifier | |
Behling et al. | Synthetic glycolipid adjuvants | |
Wannemuehler et al. | LPS regulation of the immune response: Bacteroides endotoxin induces mitogenic, polyclonal, and antibody responses in classical LPS responsive but not C3H/HeJ mice. | |
Dennert | Effector mechanisms of cell-mediated immunity to xenogeneic cell antigens | |
Hall et al. | Molecular size and subunit structure of the fourth component of guinea pig complement | |
Brondz et al. | Enrichment of effector T lymphocytes specific to H‐2 antigens by elution from allogeneic target cells and characterization of the eluted lymphocyte population | |
Lopez-Merino et al. | Immunization by an insoluble fraction extracted from Brucella melitensis: immunological and chemical characterization of the active substances | |
Boyer et al. | Stimulation of lymphoid cells from normal and immune mice by syngeneic BALB/c plasma cell tumors | |
Labib et al. | Immunosuppressive factors in mouse amniotic fluid and neonate serum |